ANI Pharma to List Through Takeover of BioSante

Unlisted ANI Pharmaceuticals Inca, a speciality and generic pharmaceutical company is listing through the purchase of BioSante Pharmaceuticals, another drugmaker, in an all-stock deal.

BioSante will issue stock to ANI shareholders giving ANI stockholders a 53% stake in the combined company.

The combined company will be renamed ANI Pharmaceuticals and be led by the ANI management team, with Arthur Przybyl serving as chief executive officer, the companies said in a joint statement.

Virtual Event

DIGITALIZATION IN THE CHEMICAL INDUSTRY

DIGITALIZATION IN THE CHEMICAL INDUSTRY

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.